Once-daily ceftriaxone for skin and soft tissue infections
- 1 April 1985
- journal article
- clinical trial
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 27 (4) , 648-649
- https://doi.org/10.1128/aac.27.4.648
Abstract
We prospectively compared once-daily administration of ceftriaxone with cefazolin given every 8 h for the treatment of skin and soft tissue infections. Thirty-one patients received cefazolin for a mean of 4.5 days, and 26 patients received ceftriaxone for a mean of 4.0 days. All patients had a satisfactory response. Adverse reactions were few and reversible. Ceftriaxone given as a single daily intramuscular injection is effective therapy for skin and soft tissue infections.Keywords
This publication has 8 references indexed in Scilit:
- Home Intravenous Antibiotic Therapy: A Team ApproachAnnals of Internal Medicine, 1983
- Cost Comparisons among Antimicrobial AgentsNew England Journal of Medicine, 1982
- Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infectionsAntimicrobial Agents and Chemotherapy, 1982
- Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluentsAntimicrobial Agents and Chemotherapy, 1982
- Ceftizoxime compared with cefamandole for treatment of soft tissue infectionsJournal of Antimicrobial Chemotherapy, 1982
- Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivativeAntimicrobial Agents and Chemotherapy, 1981
- Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporinAntimicrobial Agents and Chemotherapy, 1981
- Skin and soft tissue polymicrobial infections from intravenous abuse of drugs.1979